Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ION-682884-CS2 - A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Disease Sites: Not Available

Phase:

Investigator: Hung, Rebecca

NCTID:

Protocol No: CRE-CHF0006

LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study

Disease Sites: Not Available

Phase:

Investigator: Lindenfeld, Joann

NCTID:

Protocol No: CRE-CHF0012

OCEANIC-AF - A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke

Disease Sites: Not Available

Phase: III

Investigator: Montgomery, Jay

NCTID:

Protocol No: CRE-ARR0018

FULCRUM VT- Cryoablation for Monomorphic Ventricular Tachycardia IDE Early Feasibility Study

Disease Sites: Not Available

Phase:

Investigator: Stevenson, William

NCTID:

Protocol No: CRE-ARR0019

CY 6022 - A FOLLOW-UP, OPEN-LABEL, RESEARCH EVALUATION OF SUSTAINED TREATMENT WITH AFICAMTEN (CK-3773274) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID:

Protocol No: CRE-CHF0014

GS-US-356-5413 Study of Females Exposed to Eleclazine

Disease Sites: Not Available

Phase:

Investigator: Hung, Rebecca

NCTID:

Protocol No: CRE-CHF0013

TRISOL: EARLY FEASIBILITY STUDY OF THE TRISOL SYSTEM PROTOCOL

Disease Sites: Not Available

Phase:

Investigator: Goel, Kashish

NCTID:

Protocol No: VALV0008

RESPONDER-HF - Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure

Disease Sites: Not Available

Phase:

Investigator: Gupta, Deepak

NCTID:

Protocol No: CRE-INT0010

ION-682884-CS12 - An Open-Label Extension Study to Assess the Long-Term Safety of
Eplontersen (ION-682884) in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Disease Sites: Not Available

Phase:

Investigator: Hung, Rebecca

NCTID:

Protocol No: CRE-CHF0016

ACCESS-MANTA Registry - Prospective Clinical Registry evaluating contemporary MANTA outcomes (ACCESS-MANTA Registry)

Disease Sites: Not Available

Phase:

Investigator: Goel, Kashish

NCTID:

Protocol No: CRE-INT0012

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form